Full Text View
Tabular View
No Study Results Posted
Related Studies
Adaptive Behavior Assessment of Men With 49, XXXXY, Klinefelter Syndrome
This study has been withdrawn prior to recruitment.
Study NCT00347464   Information provided by University of Wisconsin, Madison
First Received: June 29, 2006   Last Updated: April 25, 2008   History of Changes

June 29, 2006
April 25, 2008
June 2006
 
 
 
Complete list of historical versions of study NCT00347464 on ClinicalTrials.gov Archive Site
 
 
 
Adaptive Behavior Assessment of Men With 49, XXXXY, Klinefelter Syndrome
Adaptive Behavior Assessment of Men With 49, XXXXY, Klinefelter Syndrome

Klinefelter syndrome, a congenital chromosomal abnormality with one or more extra X chromosomes, occurs in out of 400 live male births. The majority of Klinefelter men present with a 47, XXY karyotype. The "poly-X variant", with the 49,XXXXY karyotype is uncommon. This syndrome, where subjects have two or more X chromosomes presents with primary hypogonadism, and, particularly if associated with the 49,XXXXY karyotype, significantly impacts life skills across a variety of dimensions, including areas of communication, community use, functional academics, home/school living, health and safety, leisure, self-care, self direction, and work. Adaptive behavior abnormalities in 46,XXY men are well known and described. In the poly-X variant of the 49,XXXXY karyotype, adaptive behavior abnormalities are expected to be much more significant, making these patients eligible for services and Social Security benefits.

In 49,XXXXY men no study to date has examined these areas of inquiry in a large patient population, using a psychometrically sound instrument in a large patient population. Current publications are limited to individual case reports or small case summaries. It is important to study the adaptive behavior in its highly abnormal presentation in 49,XXXXY men in order to learn more about the effect of additional X chromosomes on adaptive skills, which determine how an individual responds to daily demands and in order to develop treatment and training goals.

 
 
Observational
Case-Only, Prospective
Klinefelter Syndrome
 
 
 

*   Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
 
Withdrawn
0
August 2008
 

Inclusion Criteria:

  • Any Klinefelter male with proven 49,XXXXY karyotype, who does not present with and is not being treated for significant physical/mental illness which might affect his adaptive behavior, who or whose parent or primary caretaker is able to provide informed consent to participate in the study and who or whose parent or primary caretaker has adequate command of the English language, to provide meaningful information will be invited to participate in this study.
Male
2 Years to 21 Years
No
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT00347464
Wolfram Nolten MD, University of WIsconsin
2005-295
University of Wisconsin, Madison
Solvay Pharmaceuticals
Principal Investigator: Wolfram E Nolten, MD University of Wisconsin, Madison
University of Wisconsin, Madison
April 2008

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP